+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Endometriosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767393
  • Report
  • 191 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Bayer AG
  • Ipsen SA
  • Pfizer Inc
  • Repros Therapeutics Inc
  • MORE
The global clinical trial report- “2019 Endometriosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Endometriosis. It presents in-depth analysis of Endometriosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Endometriosis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Endometriosis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Endometriosis

The research work is prepared through extensive and continuous research on Endometriosis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Endometriosis patients are identified
  • The report includes panorama of Endometriosis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Endometriosis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Astellas Pharma Inc
  • Bayer AG
  • Ipsen SA
  • Pfizer Inc
  • Repros Therapeutics Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Endometriosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Endometriosis Clinical Trials by Region
2.2.2 Average Enrollment of Endometriosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Endometriosis Treatment, 2019

3. Region wise Endometriosis Clinical Trials
3.1 Asia Pacific Endometriosis Clinical Trials by Country
3.2 Europe Endometriosis Clinical Trials by Country
3.3 North America Endometriosis Clinical Trials by Country
3.4 Middle East and Africa Endometriosis Clinical Trials by Country
3.5 South and Central America Endometriosis Clinical Trials by Country

4. Endometriosis Clinical Trial Trends
4.1 Start Year wise Endometriosis Clinical Trials
4.2 Phase wise Endometriosis Clinical Trials
4.3 Trial Status wise Endometriosis Clinical Trials
4.4 Trial Type wise Endometriosis Clinical Trials

5. Endometriosis Average Enrollment Trends
5.1 Average Enrollment in Endometriosis Trials by Year
5.2 Average Enrollment in Endometriosis Trials by Phase
5.3 Average Enrollment in Endometriosis Trials by Status
5.4 Average Enrollment in Endometriosis Trials by Type of Trial

6. Companies Participating in Endometriosis Clinical Trials
6.1 Endometriosis Trials by Sponsor Type
6.2 Endometriosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Endometriosis Trials- Phase 1
7.2 Endometriosis Trials- Phase 2
7.3 Endometriosis Trials- Phase 3
7.4 Endometriosis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Endometriosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Endometriosis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Endometriosis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Endometriosis Clinical Trials and Enrolment
Figure 7: North America - Country wise Endometriosis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Endometriosis Clinical Trials and Enrolment
Figure 9: Endometriosis Clinical Trials by Phase
Figure 10: Endometriosis Clinical Trials by Trial Status
Figure 11: Endometriosis Clinical Trials by Type
Figure 12: Endometriosis Clinical Trials by Sponsor Type
Figure 13: Endometriosis Clinical Trials by Leading Sponsors
Figure 14: Endometriosis Average Enrollment by Phase
Figure 15: Endometriosis Average Enrollment by Trial Status
Figure 16: Endometriosis Average Enrollment by Type
Figure 17: Endometriosis- Average Enrolment by Type of Sponsors
Figure 18: Endometriosis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Endometriosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Endometriosis Clinical Trials and Enrolment
Table 5: Europe - Country wise Endometriosis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Endometriosis Clinical Trials and Enrolment
Table 7: North America - Country wise Endometriosis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Endometriosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Endometriosis Average Enrollment by Phase
Table 15: Endometriosis Average Enrollment by Trial Status
Table 16: Endometriosis Average Enrollment by Type
Table 17: Endometriosis- Average Enrolment by Type of Sponsors
Table 18: Endometriosis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc
  • Astellas Pharma Inc
  • Bayer AG
  • Ipsen SA
  • Kissei Pharmaceutical Co Ltd
  • Mochida Pharmaceutical Co Ltd
  • Neurocrine Biosciences Inc
  • Pfizer Inc
  • Repros Therapeutics Inc
  • Takeda Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767393
Adroll
adroll